UPDATE: Depomed (DEPO) Shares Spike to Session Highs Amid Mallinckrodt (MNK) Chatter
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
(Updated - November 4, 2016 3:07 PM EDT)
Depomed (NASDAQ: DEPO) shares spike to session highs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Depomed (DEPO) 'Clearly' on Purdue Pharma Radar - Bloomberg
- Third-Party Said Interested in PrivateBancorp (PVTB) as CIBC (CM) Deal is Delayed
- DuPont (DD), Dow Chemical (DOW) Said to Face EU Concerns Over Research Spending - Bloomberg
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!